CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells.
about
Maraviroc: a review of its use in HIV infection and beyondCCR5 antagonism in HIV infection: current concepts and future opportunitiesRegulation of atherogenesis by chemokines and chemokine receptorsA novel small-molecule inhibitor of HIV-1 entryHIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropismFull Length Single Chain Fc Protein (FLSC IgG1) as a Potent Antiviral Therapy Candidate: Implications for In Vivo Studies.Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.Synergistic inhibition of R5 HIV-1 by maraviroc and CCR5 antibody HGS004 in primary cells: implications for treatment and preventionEnv-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors
P2860
Q26778504-3423319B-C74A-4E72-AAD2-118B78EFC93DQ26865457-0C0C4A24-9A92-45E6-80F6-E5E0840182FDQ27003124-BFBA11AA-3BDC-4034-85CF-4783272FE5A0Q28606625-FC8EE9A5-D6B8-424F-A9CC-ABC8C9021DC5Q35076868-24A94066-AA69-41D0-947F-5C8F7C75C7D6Q36602029-19F728C5-4D44-4BA0-B514-5656B4795463Q38196457-465F3A31-DEC6-400C-8246-027E604BBC0BQ39161979-4AB67BEB-8B88-4F8B-A890-A9728A9DD9A6Q39454698-543D7467-96D7-4194-B3A8-C34A77D63B61
P2860
CCR5 antibodies HGS004 and HGS101 preferentially inhibit drug-bound CCR5 infection and restore drug sensitivity of Maraviroc-resistant HIV-1 in primary cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@ast
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@en
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@nl
type
label
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@ast
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@en
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@nl
prefLabel
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@ast
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@en
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@nl
P2093
P2860
P1433
P1476
CCR5 antibodies HGS004 and HGS ...... istant HIV-1 in primary cells.
@en
P2093
Alonso Heredia
Clara Lehmann
James S Foulke
Marvin Reitz
Olga Latinovic
Robert R Redfield
P2860
P356
10.1016/J.VIROL.2010.12.029
P407
P577
2011-01-12T00:00:00Z